Cargando…
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
Drug discovery is an expensive, long, and complex process, usually with a high degree of uncertainty. In order to improve the efficiency of drug development, effective methods are demanded to screen lead molecules and eliminate toxic compounds in the preclinical pipeline. Drug metabolism is crucial...
Autores principales: | Fu, Jingyu, Qiu, Hailong, Tan, Cherie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141038/ https://www.ncbi.nlm.nih.gov/pubmed/37111785 http://dx.doi.org/10.3390/pharmaceutics15041300 |
Ejemplares similares
-
Application of microfluidic chips in anticancer drug screening
por: Fan, Xin-yue, et al.
Publicado: (2022) -
Microfluidic
Droplet-Assisted Fabrication of Vessel-Supported
Tumors for Preclinical Drug Discovery
por: Wu, Yue, et al.
Publicado: (2023) -
The Role of Microfluidics for Organ on Chip Simulations
por: Aziz, Aziz Ur Rehman, et al.
Publicado: (2017) -
Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro
por: Kanabekova, Perizat, et al.
Publicado: (2022) -
Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development
por: Li, Zening, et al.
Publicado: (2022)